Class 12 Biology Chapter 12 Biotechnology and its Applications

Key Concept: Bioactive Products, Ethical Concerns

c) Animal welfare and exploitation concerns
[Solution Description] The main ethical concern revolves around the welfare and rights of animals used in genetic engineering, as it raises questions about animal suffering and exploitation.

Key Concept: Alpha-1-antitrypsin, Vaccine Safety Testing

c) Employing transgenic mice for polio vaccine safety testing before human trials
[Solution Description] Transgenic mice are used to test polio vaccines instead of monkeys, as they are genetically modified to be more sensitive and provide quicker assessment of vaccine safety.

Key Concept: Transgenic Animals, Biological Products, Rosie

b) 12 grams
[Solution Description] To find the total amount of $\text{alpha-lactalbumin}$ in 5 litres of Rosie's milk:
Multiply the protein concentration per litre by the number of litres.
$2.4 \text{ g/L} \times 5 \text{ L} = 12 \text{ g}$

Key Concept: Genetic disorders, Huntington’s disease

c) They help in understanding disease mechanisms and testing gene therapies.
[Solution Description]
Transgenic animal models with Huntington's disease-causing mutations are primarily useful for studying the pathophysiology of the disease and evaluating potential treatments. These models express mutant huntingtin protein, leading to neurodegeneration similar to human patients, thereby providing insights into disease mechanisms and therapy development.

Key Concept: Transgenic mice models, Alzheimer’s disease

b) They produce beta-amyloid peptides that aggregate into plaques resembling human pathology.
[Solution Description]
Transgenic mice expressing human APP are used to study Alzheimer's disease because they develop amyloid plaques similar to those found in human patients. The APP gene is implicated in the production of beta-amyloid peptides, which aggregate to form these plaques. These mice help researchers understand disease progression and test potential treatments by mimicking key pathological features.

Key Concept: Applications in Gene Function Studies, Study of Diseases

b) Transgenic animals replicate the complexity of neural networks and systemic interactions.
[Solution Description]
Transgenic animals provide a complete biological system where interactions between neurons, glial cells, and other tissues can be studied in vivo, unlike isolated cell cultures. This allows researchers to observe systemic effects and complex disease progression.

Key Concept: Creation of Transgenic Animals, Biological Products

c) Electroporation of embryos.
[Solution Description]
Common methods include microinjection, retrovirus-mediated gene transfer, and embryonic stem cell-mediated gene transfer. Electroporation is primarily used for bacterial or cell culture transfection and is not standard for creating transgenic animals.

Key Concept: Gene Manipulation, Applications in Gene Function Studies

c) The foreign gene acted as a repressor of growth-related genes.
[Solution Description]
The foreign gene introduced could be functioning as a negative regulator of growth-related genes or interfering with endogenous growth pathways. Transgenic animals help reveal gene functions by observing phenotypic changes. If the gene disrupts normal physiology, it may inhibit growth, leading to stunted development.

Key Concept: Cost-Effective, Efficiency

b) Both the cost and time required for testing decrease significantly.
[Solution Description]
Transgenic animals offer cost-effective and efficient testing solutions because they are smaller, require fewer resources, and provide faster results due to their genetic modifications for heightened sensitivity. This reduces both the time and financial investment needed for large-scale testing.

Key Concept: Alternative to Traditional Methods, Ethical Reduction

c) It reduces reliance on primates, minimizing ethical concerns.
[Solution Description]
Transgenic animals like mice are used as alternatives to primates in vaccine testing, reducing the ethical concerns associated with using higher-order animals. This substitution minimizes harm to primates while maintaining testing accuracy, adhering to the principle of ethical reduction in animal testing.

Key Concept: Toxicity Testing, Early Detection of Hazards

c) The use of transgenic mice allows for early detection of toxicity due to their heightened sensitivity.
[Solution Description]
Transgenic animals are genetically modified to be more sensitive to toxic substances, enabling them to detect hazards at much lower concentrations compared to non-transgenic animals. In this case, the biomarker appears at 10 times lower concentration, indicating higher sensitivity and earlier detection capability. This aligns with the advantage of transgenic animals providing faster and more accurate results in toxicity testing.

Key Concept: Advantages, Hepatitis B Vaccine

c) They provide precise data on human-like immune responses.
[Solution Description]
The hepatitis B vaccine example demonstrates the accuracy and reliability of transgenic animals in validating vaccine safety. These animals provided precise data on adverse effects, ensuring the vaccine's safety before human trials.

Key Concept: Testing Polio Vaccine, Efficiency

c) Their genetic modification allows them to mimic human immune responses.
[Solution Description]
Transgenic mice are genetically modified to carry specific human genes that allow them to mimic human immune responses, making them suitable for testing polio vaccines. This method provides reliable safety data efficiently and reduces the need for primate testing.

Key Concept: Model Organisms, Ethical Considerations

b) They replicate human immune responses better and reduce ethical concerns.
[Solution Description]
Transgenic mice are preferred over primates due to ethical considerations and efficiency. They are genetically engineered to mimic human immune responses, providing reliable data while reducing ethical concerns associated with primate use. Moreover, they offer cost-effective and faster results compared to traditional methods.

Key Concept: Agricultural Improvements, Vaccine Safety Testing

b) Elimination of the need for live virus handling and faster production
[Solution Description]
Conventional vaccine production involves injecting viruses into fertilized eggs and harvesting viral proteins. Transgenic chickens overexpressing specific viral proteins eliminate the need for live virus handling, reducing biosafety risks, speeding up production, and potentially increasing yield since the proteins are continuously produced by the host’s own cells.

Key Concept: Study of Diseases, Ethical Concerns

b) Ensuring strict adherence to the 3Rs principle and regulatory guidelines
[Solution Description]
The ethical concerns regarding the use of transgenic animals include animal welfare, necessity of research, and alternatives. The best way to address these concerns is by following the 3Rs principle (Replacement, Reduction, Refinement). This involves minimizing animal use, improving experimental techniques to reduce suffering, and exploring alternative methods whenever possible. Regulatory oversight also ensures ethical compliance.

Key Concept: Production of Biopharmaceuticals, Xenotransplantation

c) 5 units
[Solution Description]
To solve this question:
1. The normal expression level of $\alpha$ 1,3-galactosyltransferase is given as 100 units.
2. The transgene reduces the expression by 95%.
3. A 95% reduction means only 5% of the original expression remains.
4. Calculation: $100 \, \text{units} \times 0.05 = 5 \, \text{units}$.
Therefore, the expression level in the transgenic pig will be 5 units.

Key Concept: Biosafety Issues, GEAC

c) To approve and ensure the safety of genetically modified products
[Solution Description]
The Genetic Engineering Approval Committee (GEAC) in India is responsible for evaluating and approving the use of genetically modified organisms (GMOs) to ensure their safety for public health and the environment. It assesses the risks associated with GMOs, monitors research activities, and grants permissions for field trials and commercial release of GM crops and products. GEAC plays a crucial role in maintaining biosafety standards and ensuring ethical practices in biotechnology.

Key Concept: Applications, Biological Products

b) She produced milk enriched with human alpha-lactalbumin
[Solution Description]
Rosie, the first transgenic cow, produced milk containing human alpha-lactalbumin, a protein found in human breast milk. This achievement demonstrated the potential of transgenic animals to produce biologically significant human proteins. The milk produced by Rosie contained 2.4 grams of human protein per litre, making it a potential alternative for infant nutrition and showcasing the application of transgenic technology in producing therapeutic and nutritional products.

Key Concept: Methods of Gene Transfer, Applications

d) Microinjection
[Solution Description]
Microinjection is the predominant method used for producing transgenic farm animals. This technique involves the direct injection of foreign DNA into the pronucleus of a fertilized egg using a fine glass needle. The injected DNA integrates randomly into the host genome, leading to the creation of transgenic animals. Other methods like retrovirus-mediated or embryonic stem cell-mediated gene transfer are less commonly used for farm animals compared to microinjection.

Key Concept: Applications, Ethical Considerations

d) They can be more sensitive to toxic substances
[Solution Description]
The question focuses on the application of transgenic mice in vaccine safety testing. According to the syllabus, transgenic mice are used because they can be engineered to be more sensitive to toxic substances, allowing quicker and safer assessment compared to using monkeys.

Key Concept: Methods of Gene Transfer, Characteristics

b) Microinjection
[Solution Description]
The question asks about the primary method used for creating transgenic animals. As per the syllabus, microinjection is the predominant method for this purpose, where a foreign gene is directly injected into the host DNA.

Key Concept: Genetic Modification, Applications

d) Alpha-lactalbumin
[Solution Description]
The question asks about the human protein produced in the milk of Rosie, a transgenic cow. According to the syllabus, Rosie produced milk rich in human alpha-lactalbumin (2.4 grams per litre), which is suitable as an alternative for babies.

Key Concept: Disease Study Models, Ethical Aspects

c) Lower ethical concerns and faster experimentation
[Solution Description]
Transgenic mice are preferred over monkeys for polio vaccine safety testing due to ethical concerns, lower maintenance costs, and faster breeding cycles. Monkeys are more closely related to humans, but their use raises significant ethical issues. Additionally, transgenic mice can be genetically modified to mimic human responses, making them practical and ethically acceptable substitutes.

Key Concept: Applications, Biological Products

c) 120 grams
[Solution Description]
To find the total amount of human alpha-lactalbumin produced, multiply the concentration by the volume:
$2.4 \, \text{g/L} \times 50 \, \text{L} = 120 \, \text{g}$
The calculation shows that 50 litres of milk contain 120 grams of the protein.

Key Concept: Transgenic Animals, Gene Transfer Methods

c) Ensures stable integration with higher efficiency
[Solution Description]
Retrovirus-mediated gene transfer has an advantage over microinjection because it allows for stable integration of the transgene into the host genome at higher efficiency. Microinjection requires precise insertion of DNA into the pronucleus of fertilized eggs, which can be technically challenging and less efficient. In contrast, retroviruses naturally integrate their genetic material into the host's genome, ensuring higher success rates in transgenesis.

Key Concept: Pharmaceutical production

d) Human antithrombin
[Solution Description]
Transgenic goats are engineered to produce human antithrombin, a protein that prevents blood clots. This is one of the key examples of pharmaceuticals derived from transgenic animals.

Key Concept: Transgenic animals in vaccine safety

c) They are genetically modified to better mimic human responses.
[Solution Description]
Transgenic mice are genetically modified to be more sensitive to substances, allowing quicker and more efficient testing of vaccine safety. If successful, they can replace monkeys, reducing ethical concerns and logistical challenges.

Key Concept: Biological products

c) Alpha-1-antitrypsin
[Solution Description]
The question asks about the human protein produced by transgenic animals for treating emphysema. From the given information, it is clear that Alpha-1-antitrypsin is the protein used for this purpose.

Key Concept: Genetic Disorders

d) To explore gene therapy and drug efficacy
[Solution Description]
Transgenic models for genetic disorders such as cystic fibrosis allow scientists to study disease mechanisms, test gene therapy approaches, and evaluate drug efficacy before human trials. These models bridge the gap between laboratory research and clinical applications.

Key Concept: Disease Research

d) They are modified to carry disease-linked genes for study.
[Solution Description]
Transgenic mice are modified to carry specific genes associated with diseases, allowing researchers to study the role of these genes in disease development. They serve as effective model organisms due to their genetic similarity to humans and ease of manipulation.

Key Concept: Applications of Transgenic Animals

b) Her milk contained human protein alpha-lactalbumin.
[Solution Description]
The first transgenic cow, Rosie, produced milk containing human protein alpha-lactalbumin (2.4 grams per litre). This demonstrated the potential of transgenic animals to produce nutritionally enhanced products for human consumption, serving as an alternative for babies.

Key Concept: Gene Transfer Methods

c) Gene transfer by microinjection
[Solution Description]
The predominant method for creating transgenic animals involves the introduction of a foreign gene into their genome using microinjection. This technique allows precise insertion of the gene into the nucleus of a fertilized egg cell.

Key Concept: Ethical Concerns in Transgenic Animal Use

c) Moral implications of genetically modifying animals
[Solution Description]
A significant ethical concern regarding the use of transgenic animals is the moral implications of genetically modifying animals for human benefit, including potential suffering or unintended harm caused by these modifications. Other concerns include regulatory hurdles, but the primary issue revolves around ethics.

Key Concept: Applications of Transgenic Animals

c) Agricultural crop improvement
[Solution Description]
Transgenic animals are commonly used for drug safety testing, environmental toxicity assessment, and cosmetic testing. However, they are not typically used for agricultural crop improvement, as this application involves direct genetic modification of plants rather than animals.

Key Concept: Transgenic Animals in Chemical Safety Testing

c) Enhanced sensitivity to toxic substances leading to faster hazard detection
[Solution Description]
The primary advantage of using transgenic animals in chemical safety testing is their enhanced sensitivity to toxic substances due to genetic modifications. This allows for early detection of potential hazards and reduces the need for extensive animal testing since fewer animals are required to obtain reliable results.

Key Concept: Advantages of Transgenic Animals

c) Allows for rapid and efficient testing of vaccine batches
[Solution Description]
Transgenic animals enable rapid batch testing and reduce adverse effects in humans by identifying potential issues early. This method is faster and more controlled compared to traditional primate testing.

Key Concept: Vaccine Safety Testing Applications

b) Polio vaccine
[Solution Description]
According to the syllabus, transgenic mice are being used specifically to test the safety of the polio vaccine before its administration to humans. This ensures reliability and identifies potential issues early.

Key Concept: Transgenic Animals in Vaccine Safety Testing

b) Provides a more ethical alternative to using primates
[Solution Description]
The primary advantage of using transgenic animals like mice instead of primates is that it provides a more ethical alternative, reducing the need to use higher-order animals for testing. It also allows for efficient and rapid testing of vaccine batches while minimizing risks to human health.

Key Concept: Xenotransplantation

c) Pigs
[Solution Description]
According to the syllabus, pigs are genetically modified to produce organs or tissues for xenotransplantation due to their physiological similarity to humans, reducing organ rejection risks.

Key Concept: Vaccine Safety Testing

c) To evaluate potential side effects and immune responses in a controlled biological system
[Solution Description]
Transgenic animals serve as models to test the safety and efficacy of vaccines before they are approved for human use, as mentioned in the syllabus under Vaccine Safety Testing.

Key Concept: Production of Bioactive Products

c) Alpha-1-antitrypsin
[Solution Description]
The syllabus mentions that alpha-1-antitrypsin is a bioactive product produced by transgenic animals and is specifically used in the treatment of emphysema.

Key Concept: CRISPR-Cas9 Gene Editing

c) It enables precise targeting of specific genomic locations
[Solution Description]
The CRISPR-Cas9 system allows for precise editing of the genome by introducing double-strand breaks at specific target sites, which are then repaired by the cell's machinery to incorporate the desired transgene. This method offers higher specificity and efficiency compared to random integration techniques like microinjection or retroviral vectors.

Key Concept: Retrovirus-Mediated Gene Transfer

c) Highly efficient integration of the transgene
[Solution Description]
Retrovirus-mediated gene transfer allows the efficient integration of foreign DNA into the host genome due to the natural ability of retroviruses to insert their genetic material into the host DNA. This method is particularly useful for introducing genes into embryonic stem cells or early embryos. However, the size of the transgene is limited.

Key Concept: Microinjection

c) Inability to target specific genomic locations
[Solution Description]
The microinjection method involves injecting foreign DNA directly into the pronucleus of a fertilized egg, which can lead to random integration of the transgene. This randomness may result in variable expression levels or disruption of essential genes. Additionally, the method requires specialized equipment and skilled personnel.

Key Concept: Applications of Transgenic Animals

c) Studying human diseases and testing treatments
[Solution Description]
Transgenic animals serve as model organisms to study diseases such as cancer and Alzheimer's, allowing researchers to understand disease mechanisms and test potential treatments.

Key Concept: Examples of Transgenic Animals

c) Mice
[Solution Description]
The first transgenic animal produced using genetic engineering techniques was mice in 1982. This milestone paved the way for other transgenic animals like cows, sheep, and pigs.

Key Concept: Characteristics of Transgenic Animals

b) They contain a foreign gene artificially introduced into their DNA
[Solution Description]
A transgenic animal is created by introducing a foreign gene into its DNA, and this gene can be expressed and passed on to offspring. The correct option should reflect this key feature.

Key Concept: Ethical and Regulatory Aspects

b) GEAC (Genetic Engineering Approval Committee)
[Solution Description]
The Genetic Engineering Approval Committee (GEAC) in India regulates the approval, testing, and large-scale use of genetically modified organisms, ensuring biosafety and ethical compliance.

Key Concept: Applications of Transgenic Animals

d) Alpha-lactalbumin
[Solution Description]
Rosie, the first transgenic cow (1997), produced milk containing the human alpha-lactalbumin protein, which provided an alternative to natural cow milk for babies.

Key Concept: Methods of Creating Transgenic Animals

d) Microinjection
[Solution Description]
Microinjection is the predominant method used to create transgenic animals, where foreign DNA is directly injected into the pronucleus of a fertilized egg using a fine glass needle.

Key Concept: Vaccine safety testing

d) They are more sensitive to substances due to genetic modifications
[Solution Description]
Transgenic mice are genetically modified to be more sensitive to substances, allowing quicker and safer testing of vaccines like polio. They can potentially replace monkeys for this purpose.

Key Concept: Use of transgenic animals

c) She produced milk rich in $\text{alpha-lactalbumin}$
[Solution Description]
Rosie was notable for producing milk enriched with the human protein $\text{alpha-lactalbumin}$. Her milk contained $2.4 \text{ grams protein per litre of milk}$ and served as an alternative for babies.

Key Concept: Biological products from transgenic animals

c) $\text{Alpha-1-antitrypsin}$
[Solution Description]
The protein used to treat emphysema is $\text{Alpha-1-antitrypsin}$, as mentioned in the syllabus. It is specifically highlighted as a key biological product obtained from transgenic animals.

Key Concept: Advantages of transgenic models

c) They provide a controlled environment for disease study and drug testing
[Solution Description]
Transgenic animals provide a controlled environment to study diseases, allow drug testing before human trials, and help understand genetic disorders.

Key Concept: Transgenic models for cancer

c) Oncogenes or tumor suppressor genes
[Solution Description]
Transgenic animals for cancer research are often engineered with oncogenes (cancer-causing genes) or tumor suppressor genes to mimic human cancer development.

Key Concept: Transgenic models for Alzheimer's disease

c) To study the progression of Alzheimer's disease and test treatments
[Solution Description]
Transgenic mice with the human APP gene are used to study the progression of Alzheimer's disease and test potential treatments, as they mimic the disease's pathological features.

Key Concept: Key Points

c) $\alpha$-lactalbumin
[Solution Description]
The transgenic cow Rosie produced milk rich in the human protein $\alpha$-lactalbumin.

Key Concept: Applications in Studying Gene Function

d) Studying disease mechanisms and drug development
[Solution Description]
Transgenic animals are used to study diseases like Alzheimer’s and cancer, helping understand gene roles and develop treatments.

Key Concept: Methods of Gene Transfer

d) Gene transfer by microinjection
[Solution Description]
The predominant method for producing transgenic farm animals is gene transfer by microinjection, as it is efficient and widely adopted.

Key Concept: Advantages

d) It reduces the need for testing on non-transgenic animals
[Solution Description]
Using transgenic animals for chemical safety testing provides several advantages, such as more accurate results compared to traditional animal testing, reduced need for testing on non-transgenic animals, and early detection of potential hazards.

Key Concept: Mechanism

c) By carrying genes that make them more susceptible to chemicals
[Solution Description]
Transgenic animals carry specific genes that make them more susceptible to certain chemicals. For example, mice with human genes can be used to test the toxicity of drugs intended for humans, providing more accurate results compared to traditional methods.

Key Concept: Purpose of Chemical Safety Testing

d) To assess the toxicity and safety of chemicals and pharmaceuticals
[Solution Description]
The primary purpose of using transgenic animals in chemical safety testing is to assess the toxicity and safety of chemicals, pharmaceuticals, and other substances by making these animals more sensitive to toxic substances. This helps in evaluating potential hazards before approval for human use.

Key Concept: Advantages of Transgenic Animals

c) Faster results compared to traditional methods
[Solution Description]
One advantage of using transgenic animals is that they provide faster results compared to traditional methods, along with reduced reliance on non-human primates.

Key Concept: Replacement for Monkeys

c) They provide more controlled and specific testing conditions
[Solution Description]
Transgenic mice are more reliable and ethical alternatives to monkeys, which were traditionally used for vaccine safety testing.

Key Concept: Role in Vaccine Safety Testing

b) To identify potential side effects and immune responses of vaccines
[Solution Description]
Transgenic animals, particularly mice, are used to evaluate the safety and efficacy of vaccines by determining potential side effects and immune responses.

Key Concept: Xenotransplantation

c) To reduce the risk of organ rejection in human transplants
[Solution Description]
Transgenic pigs are engineered to produce organs compatible with human immune systems, reducing the risk of organ rejection in transplants.

Key Concept: Vaccine Safety Testing

c) To ensure vaccines are safe and effective for humans
[Solution Description]
Transgenic animals are used to test the safety and efficacy of vaccines before they are administered to humans, ensuring that the vaccines are safe and effective.

Key Concept: Production of Bioactive Products

d) Alpha-1-antitrypsin
[Solution Description]
Transgenic sheep are engineered to produce alpha-1-antitrypsin in their milk, which is used in the treatment of emphysema.

Key Concept: CRISPR-Cas9

d) CRISPR-Cas9 Gene Editing
[Solution Description]
CRISPR-Cas9 is a modern gene-editing technique that enables precise modifications, such as gene knockouts or insertions, at specific locations in the genome. It uses a guide RNA (gRNA) to direct the Cas9 enzyme to the target DNA sequence, resulting in highly efficient and accurate edits.

Key Concept: Retrovirus-Mediated Gene Transfer

b) Size restriction on the foreign gene and risk of insertional mutagenesis
[Solution Description]
Retrovirus-mediated gene transfer uses retroviruses as vectors to deliver foreign genes into the host genome. A major limitation of this method is the size constraint on the foreign gene that can be inserted and the risk of insertional mutagenesis, where the viral DNA disrupts important host genes.

Key Concept: Microinjection

c) Microinjection
[Solution Description]
The microinjection method is used to create transgenic animals by directly injecting foreign DNA into the pronucleus of a fertilized egg. This DNA integrates randomly into the host genome, and the egg is then implanted into a surrogate mother. This method is commonly used for mice, rabbits, pigs, and cattle.

Key Concept: Safety Testing

b) Vaccine safety
[Solution Description]
Transgenic animals serve as model organisms for testing vaccine safety before human trials. They are made more sensitive to substances than normal animals to study effects quickly.

Key Concept: Applications

c) Alpha-lactalbumin
[Solution Description]
The first transgenic cow Rosie produced milk containing alpha-lactalbumin, a human protein, at 2.4 grams per liter. This was intended as an alternative to natural cow milk for babies.

Key Concept: Basic Definition

b) An organism with artificially introduced foreign genes
[Solution Description]
A transgenic animal is an organism in which a foreign gene has been artificially transferred. This makes the animal genetically modified or engineered. The first transgenic animal was mice produced in 1982.

Key Concept: Applications of Transgenic Animals

b) Human alpha-lactalbumin-enriched milk
[Solution Description]
Rosie, the first transgenic cow, produced milk rich in human alpha-lactalbumin, a nutritional supplement.

Key Concept: Methods of Gene Transfer

c) Microinjection
[Solution Description]
Microinjection is the predominant method where DNA is directly injected into the nucleus of a fertilized egg to produce transgenic animals.

Key Concept: Definition of Transgenic Animals

c) An animal whose genome contains foreign genes from another species
[Solution Description]
A transgenic animal is one whose genome has been altered to carry genes from another species. The foreign gene introduced artificially into the organism is called a transgene.

Key Concept: Insertional Mutagenesis, Limited Scope

d) It increases the likelihood of unintended genetic disruptions
[Solution Description]
Insertional mutagenesis occurs when the therapeutic gene integrates into the host genome and disrupts normal gene function, potentially causing cancer or other disorders. This risk limits the scope of gene therapy because only certain genetic disorders can be safely targeted without posing significant harm.

Key Concept: Short-lived Effects, Ethical Concerns

c) Short-lived effects require repeated doses, raising safety and ethical questions
[Solution Description]
In rapidly dividing cells, the therapeutic effects of gene therapy may not last long due to dilution as cells divide. Repeated treatments are thus needed but increase the risk of side effects like immune reactions. Ethically, this raises concerns about long-term safety and the unknown consequences of multiple interventions.

Key Concept: Delivery Challenges, Immune Responses

d) They evoke strong immune responses in patients
[Solution Description]
Viral vectors, though efficient, can trigger immune responses when used in gene therapy. The body recognizes these vectors as foreign invaders, leading to inflammation or other adverse reactions. This immune response reduces the effectiveness of the treatment and poses safety risks, making it a major limitation.

Key Concept: Gene Insertion, Culture Techniques

b) Growing genetically altered lymphocytes in culture to verify gene activity.
[Solution Description]
After introducing the functional ADA gene using a retroviral vector, the lymphocytes are cultured outside the body. This culture step allows verification of successful gene insertion and expression (activity) of the ADA enzyme before the cells are reintroduced into the patient.

Key Concept: Molecular Tools, Early Embryonic Intervention

c) Germline integration ensures lifelong expression of ADA in all relevant cells.
[Solution Description]
Introducing the ADA gene at an early embryonic stage allows the gene to integrate into germline cells, leading to lifelong expression in all cell types derived from these cells. This ensures a permanent cure as opposed to the temporary solution provided by lymphocyte-based therapy.

Key Concept: Gene Therapy Process, Retroviral Vector, Limitations

d) Genetically modified lymphocytes have a limited lifespan and require regular replacement.
[Solution Description]
The genetically engineered lymphocytes containing the functional ADA gene are not immortal and have a limited lifespan in the patient's body. Since these cells die over time, they need to be replenished through periodic infusions to maintain sufficient ADA enzyme levels for immune function.

Key Concept: Vector selection, Immune response

b) Random integration of the vector DNA into the host genome.
[Solution Description]
Retroviruses integrate the therapeutic gene into the host genome, which can disrupt regulatory regions or activate oncogenes, triggering immune surveillance. Additionally, viral proteins expressed by the vector may be recognized as foreign antigens, leading to immune rejection. Unlike non-integrating vectors (e.g., AAV), retroviruses pose higher immunogenicity risks due to genomic integration and sustained viral protein expression.

Key Concept: Ethical considerations, Germline modifications

d) Inheritance of edited genes by offspring without their consent.
[Solution Description]
Germline modifications affect all cells in the organism, including reproductive cells, meaning changes are heritable and impact future generations. This raises ethical concerns about unintended consequences, consent of unborn individuals, and potential misuse (e.g., designer babies). Somatic therapy targets only specific tissues and avoids these issues. The key concern here is the irreversible alteration of the human gene pool.

Key Concept: Gene therapy methods, Ex vivo vs In vivo

d) Utilize adeno-associated virus (AAV) with muscle-specific promoters for systemic in vivo delivery.
[Solution Description]
Since DMD affects multiple muscle groups, **in vivo delivery** via a viral vector (e.g., AAV) directly into the bloodstream ensures systemic distribution. Using **non-integrating vectors** reduces the risk of insertional mutagenesis, while tissue-specific promoters can enhance long-term expression without causing immune responses. Ex vivo therapy is impractical due to the difficulty of extracting and reintroducing muscle cells. Thus, direct in vivo administration with modified AAV is optimal.

Key Concept: Gene Therapy, Transgenic Animals, Ethical Considerations

c) They provide a human-like response to vaccines for safety testing.
[Solution Description]
Transgenic animals (e.g., mice) are genetically modified to express human genes or pathogens, serving as models for studying diseases and vaccine safety. For polio, they help evaluate vaccine efficacy and side effects without risking human subjects. Ethical oversight (e.g., by GEAC) ensures responsible use.

Key Concept: Gene Therapy, Molecular Diagnosis, PCR

b) It amplifies DNA to detectable levels for early diagnosis.
[Solution Description]
PCR (Polymerase Chain Reaction) amplifies trace amounts of pathogen or defective DNA, enabling early diagnosis even before symptoms manifest. It involves cycles of denaturation, annealing, and extension to exponentially increase DNA copies. For example, PCR can detect HIV DNA in asymptomatic patients, allowing timely intervention.

Key Concept: Gene Therapy, SCID, Retroviral Vectors

c) They integrate the therapeutic gene into the host genome for stable expression.
[Solution Description]
Retroviral vectors are used in gene therapy for SCID because they can efficiently integrate the therapeutic gene (e.g., ADA gene) into the host genome of target cells (like lymphocytes). This ensures stable expression of the functional protein (ADA enzyme), addressing the root cause of the disease. The viruses are modified to carry normal human DNA and cannot replicate, making them safe for therapy.

Key Concept: Multigene Disorders

c) Targeting a single gene may not suffice due to disease complexity
[Solution Description]
Many diseases involve multiple genes, making single-gene targeting insufficient for effective treatment. Since gene therapy typically targets one gene at a time, it may not address the complexity of multigene disorders effectively.

Key Concept: Short-lived Effects

c) The introduced genes may not integrate stably, making effects temporary
[Solution Description]
In some cases, the therapeutic genes introduced during gene therapy may not integrate stably into the host genome. As a result, the effects are short-lived, especially for diseases requiring long-term correction, necessitating repeated treatments.

Key Concept: Delivery Challenges

c) They can cause immune responses, leading to inflammation or rejection
[Solution Description]
Viral vectors are commonly used for delivering therapeutic genes, but they can trigger immune responses, leading to inflammation or rejection. This poses a significant challenge in gene therapy as it reduces the efficacy and safety of the treatment.

Key Concept: Permanent Cure for ADA Deficiency

c) The gene integrates into all cell types, including germ cells
[Solution Description]
Introducing the ADA gene at an early embryonic stage allows the gene to be incorporated into all cell lineages, including germline cells, ensuring lifelong expression of the functional ADA enzyme. This prevents the need for repeated treatments.

Key Concept: Vector Use in Gene Therapy

d) Genetically disabled retrovirus
[Solution Description]
A genetically disabled retrovirus is commonly used as a vector in gene therapy for ADA-SCID. Retroviruses are chosen because they can integrate the ADA gene into the host's genome, ensuring stable expression in the T-cells.

Key Concept: Gene Therapy for ADA Deficiency

d) Lymphocytes are not stem cells and hence have a finite lifespan
[Solution Description]
Lymphocytes used in gene therapy for ADA deficiency are not immortal, meaning they have a limited lifespan. Since these cells eventually die, the patient needs repeated infusions of genetically engineered lymphocytes to maintain adequate ADA enzyme levels.

Key Concept: Gene Therapy Applications

d) Severe Combined Immunodeficiency (SCID)
[Solution Description]
Severe Combined Immunodeficiency (SCID) is a genetic disorder where patients lack a functional immune system. Gene therapy has been used to introduce a functional gene, restoring immune function in affected individuals. This is one of the notable applications of gene therapy.

Key Concept: Vectors in Gene Therapy

c) Viral vectors
[Solution Description]
Viral vectors, such as retroviruses or adenoviruses, are often used in gene therapy due to their natural ability to efficiently deliver genetic material into host cells. They can be modified to carry therapeutic genes while being rendered non-pathogenic.

Key Concept: Gene Therapy Concept

c) To correct genetic disorders by introducing functional genes into cells
[Solution Description]
The primary goal of gene therapy is to correct genetic disorders at the molecular level by delivering therapeutic genes into a patient's cells to replace or supplement non-functional or missing genes. This involves introducing functional genes using vectors like viral or non-viral carriers.

Key Concept: Gene Therapy Challenges

c) They are non-immortal and require repeated infusions
[Solution Description]
Lymphocytes are non-immortal cells, meaning they have a limited lifespan. As a result, repeated infusions of genetically corrected lymphocytes are required to maintain therapeutic benefits, making the treatment less efficient compared to targeting immortal cells like stem cells.

Key Concept: Molecular Diagnosis

d) PCR
[Solution Description]
The Polymerase Chain Reaction (PCR) is widely used for amplifying pathogen nucleic acids, enabling early detection of infections or mutations. This helps identify suitable candidates for gene therapy by confirming the presence or absence of specific genetic defects.

Key Concept: Vector Delivery in Gene Therapy

c) Retrovirus
[Solution Description]
The correct vector used in gene therapy for ADA deficiency is a retroviral vector. Retroviruses are effective because they can integrate their genetic material into the host cell's DNA, allowing stable expression of the therapeutic gene (ADA). Other vectors like plasmids or adenoviruses do not provide stable integration for long-term gene correction.

Key Concept: Risk of Insertional Mutagenesis

c) Disruption of essential genes or activation of oncogenes
[Solution Description]
When viral vectors integrate the therapeutic gene into the host genome, there is a risk of disrupting essential genes or activating oncogenes. This could potentially lead to cancer, a condition known as insertional mutagenesis.

Key Concept: Short-lived Effects

c) The gene fails to integrate and is lost during cell division
[Solution Description]
If the introduced gene does not integrate into the host genome, it may be lost during cell division. This results in the need for repeated treatments, making the therapeutic effects short-lived.

Key Concept: Delivery Challenges

c) Immune response leading to inflammation or rejection
[Solution Description]
Viral vectors, though efficient in delivering therapeutic genes, often trigger immune responses in the body. This can lead to inflammation or rejection of the vector, reducing the effectiveness of the therapy. Thus, immune response is a significant challenge.

Key Concept: Process of Gene Therapy

b) Because the lymphocytes have a limited lifespan and need replenishment
[Solution Description]
Lymphocytes are not immortal; they have a limited lifespan. Therefore, even after introducing the functional ADA gene into these cells, the patient needs periodic infusions of new genetically engineered lymphocytes to maintain adequate levels of ADA enzyme in the body.

Key Concept: Vectors in Gene Therapy

b) Genetically altered retroviruses
[Solution Description]
The most common vectors used in gene therapy for ADA deficiency are genetically altered retroviruses. These viruses are modified to carry the normal human ADA gene and transfer it into the patient's target cells (such as T-cells).

Key Concept: Gene Therapy Concept

b) To introduce a functional ADA gene and restore immune function
[Solution Description]
The primary goal of gene therapy for ADA deficiency is to introduce a functional ADA gene into the patient's cells to enable them to produce the missing enzyme, adenosine deaminase. This helps in restoring normal immune function.

Key Concept: Application of Gene Therapy

c) Adenosine deaminase (ADA) gene
[Solution Description]
SCID is caused by defects in the adenosine deaminase (ADA) gene, leading to a non-functional immune system. Gene therapy for SCID involves introducing a functional ADA gene into the patient's cells to restore immune function. This example is well-documented in gene therapy applications.

Key Concept: Vectors in Gene Therapy

b) Retrovirus
[Solution Description]
Vectors are vehicles used to deliver the therapeutic gene into the patient's cells. Retroviruses and adenoviruses are commonly used vectors in gene therapy because they can efficiently transfer genes into host cells. Retroviruses integrate their genetic material into the host genome, while adenoviruses remain episomal.

Key Concept: Concept of Gene Therapy

a) To cure genetic disorders by replacing defective genes
[Solution Description]
The primary goal of gene therapy is to introduce a functional gene into an individual's cells to replace or compensate for a defective or non-functional gene that causes a genetic disorder. This directly addresses the root cause of the disease rather than just managing symptoms.

Key Concept: Process of Gene Therapy

c) Reimplanting the modified T-cells into the patient
[Solution Description]
The final step involves reimplanting the genetically modified T-cells back into the patient, where they begin producing the ADA enzyme.

Key Concept: ADA Deficiency Treatment

b) Retrovirus
[Solution Description]
In the treatment of ADA deficiency (Severe Combined Immunodeficiency - SCID), a retroviral vector is used to carry the functional ADA gene into the patient's lymphocytes.

Key Concept: Gene Therapy Concept

b) To replace faulty or absent genes with functional ones
[Solution Description]
Gene therapy aims to correct genetic defects by replacing faulty or absent genes with functional ones, enabling the body to produce the necessary proteins or enzymes and eliminating the root cause of the disease.

Key Concept: Drug Testing, Disease Modeling

d) Stem cell-derived cells better mimic human pathophysiology than animal models.
[Solution Description]
Stem cell-derived human cardiomyocytes provide a more accurate model of human heart physiology compared to animal models, reducing species-specific discrepancies in drug response and improving predictive validity for clinical outcomes.

Key Concept: Gene Therapy, Pluripotency Markers

b) Oct4, Sox2, Nanog
[Solution Description]
Hematopoietic stem cells (HSCs) are multipotent. To confirm their reprogramming into pluripotent stem cells, markers like $Oct4$, $Sox2$, and $Nanog$—specific to pluripotency—must be expressed. These are not typically expressed in HSCs.

Key Concept: Regenerative Medicine, Ethical Issues

c) iPSCs do not require the destruction of embryos.
[Solution Description]
Embryonic stem cells (ESCs) require the destruction of embryos, raising ethical concerns. Induced pluripotent stem cells (iPSCs) are reprogrammed from adult somatic cells, avoiding embryo destruction and thus providing an ethical alternative while maintaining pluripotency.

Key Concept: Potency Types, Clinical Applications

c) Pluripotent stem cells for broad differentiation potential.
[Solution Description]
For regenerating multiple tissue types from a single cell source, pluripotent stem cells would be most suitable due to their ability to differentiate into all cell types of the body.
Step-by-step explanation:
1) Totipotent cells could also differentiate broadly but are ethically challenging and unnecessary for non-embryonic tissues.
2) Pluripotent cells can generate all cell types needed for most tissue regeneration therapies without forming extraembryonic tissues.
3) Their broad differentiation potential makes them ideal for multi-tissue regeneration applications.

Key Concept: Stem Cell Characteristics, Therapeutic Applications

c) Their capacity of multilineage differentiation into specialized neurons.
[Solution Description]
The primary characteristic of stem cells that makes them effective for treating neurodegenerative diseases like Parkinson's is their capacity for multilineage differentiation, allowing them to replace damaged neurons.
Step-by-step explanation:
1) Stem cells can self-renew, but this alone doesn't help in treatment without differentiation.
2) Their ability to differentiate into specialized cells (multilineage differentiation) allows them to replace lost or damaged neurons.
3) This property is specifically utilized in neuron replacement therapies for Parkinson's and Huntington's diseases.

Key Concept: Totipotent and Pluripotent Stem Cells

c) Only totipotent stem cells can form extraembryonic tissues, while pluripotent stem cells cannot.
[Solution Description]
Totipotent stem cells have the highest developmental potential as they can form both embryonic and extraembryonic tissues, leading to a complete organism. Pluripotent stem cells are derived from totipotent cells but can only differentiate into all cell types of the body, not extraembryonic tissues.
Step-by-step explanation:
1) Totipotent cells are produced by early blastomeres and can develop into a complete organism, including placental tissue.
2) Pluripotent cells are descendants of totipotent cells and can differentiate into all cell types of the body but cannot form extraembryonic structures like the placenta.
3) Therefore, the key difference lies in the ability to form extraembryonic tissues.

Key Concept: Stem cell characteristics, differentiation

c) Embryonic cells can generate more diverse specialized cells
[Solution Description]
From the syllabus:
1) Embryonic stem cells are the most versatile (pluripotent) and can differentiate into all cell types.
2) Adult stem cells from bone marrow are multipotent and limited to forming blood and immune system cells.
3) This difference in potency means embryonic stem cells would show broader differentiation capacity in experiments.

Key Concept: Stem cell therapy applications, adult stem cells

c) Leukemia
[Solution Description]
From the syllabus:
1) Adult stem cells from bone marrow have been used for spinal cord injury, liver cirrhosis, chronic limb ischemia etc.
2) Bone marrow transplant is the most widely used stem cell therapy for blood-related disorders.
3) Among the options, leukemia is a blood cancer where bone marrow transplants (using adult stem cells) are routinely used.
Other options either use different stem cell types or are not mentioned as typical bone marrow applications.

Key Concept: Stem cell potency, types

b) Pluripotent stem cells
[Solution Description]
The question describes cells that can differentiate into all cell types derived from the three embryonic germ layers (ectoderm, mesoderm, endoderm) but cannot form extraembryonic tissues. According to the syllabus:
1) Totipotent cells can form both embryonic and extraembryonic tissues (complete organism).
2) Pluripotent cells are descendants of totipotent cells and can form all three germ layers but not extraembryonic tissues.
3) Multipotent cells can only form closely related family cells.
Therefore, pluripotent is the correct answer.

Key Concept: Stem Cell Types, Regenerative Medicine

c) Leukemia
[Solution Description]
Hematopoietic stem cells (HSCs) are multipotent and primarily give rise to blood cell lineages. They are commonly used in bone marrow transplants to treat blood-related disorders such as leukemia, sickle-cell anemia, and thalassemia. These diseases involve abnormalities in blood cell production, which HSCs can address by regenerating healthy blood cells.

Key Concept: Stem Cell Therapy, Applications

d) Formation of teratomas
[Solution Description]
Pluripotent stem cells, while capable of differentiating into various cell types, pose a risk of forming teratomas (tumors) due to their uncontrolled proliferation. This is a major challenge in therapies like spinal cord injury repair, where precise control over cell differentiation and integration is essential.

Key Concept: Stem Cell Potency, Ethical Issues

c) Induced pluripotent stem cells (iPSCs) derived from adult somatic cells
[Solution Description]
To address Parkinson's disease, stem cells with high differentiation potential are needed, preferably without ethical concerns. Induced pluripotent stem cells (iPSCs) are derived from adult cells reprogrammed to a pluripotent state, avoiding embryo destruction. They can differentiate into dopaminergic neurons, making them suitable for Parkinson's therapy.

Key Concept: Ethical Considerations

c) They are derived without destroying embryos
[Solution Description]
Induced pluripotent stem cells (iPSCs) are derived from reprogramming adult somatic cells, such as skin cells, back into a pluripotent state. This avoids the ethical concerns associated with the destruction of embryos, making iPSCs a more ethically acceptable option for research and therapy.

Key Concept: Neurodegenerative Diseases

d) Replacing dopaminergic neurons
[Solution Description]
Stem cells can be differentiated into dopaminergic neurons, which are lost in Parkinson's disease patients. By replacing these damaged neurons, stem cell therapy offers a potential treatment to restore motor function and alleviate symptoms of the disease.

Key Concept: Regenerative Medicine

d) Hematopoietic stem cells
[Solution Description]
Hematopoietic stem cells are the primary type of stem cells used in bone marrow transplants for treating blood disorders such as leukemia. These cells have the ability to differentiate into all types of blood cells, making them ideal for regenerating the patient's blood and immune system.

Key Concept: Multipotent Stem Cells

c) They have the potential to differentiate into multiple cell types but within a specific lineage.
[Solution Description]
Multipotent stem cells can differentiate into a limited number of cell types, typically restricted to a specific lineage, unlike pluripotent or totipotent cells, which have broader differentiation potential.

Key Concept: Pluripotent Stem Cells

c) They can develop into any cell type except those required for placental development.
[Solution Description]
Pluripotent stem cells are descendants of totipotent cells and possess the ability to differentiate into all cell types in the body, though they cannot form a complete organism like totipotent cells.

Key Concept: Totipotent Stem Cells

c) These cells can differentiate into all embryonic cell types and develop into a complete organism.
[Solution Description]
Totipotent stem cells are produced by early blastomeres and have the unique ability to develop into a complete organism. They can differentiate into all embryonic cell types, making them distinct from pluripotent or multipotent stem cells.

Key Concept: Types of Stem Cells

c) Adult stem cells
[Solution Description]
Adult stem cells, particularly hematopoietic stem cells found in bone marrow, are commonly used in bone marrow transplants to treat blood-related disorders like leukemia and immune deficiencies.

Key Concept: Potency of Stem Cells

a) Totipotent cells can form a complete organism, while pluripotent cells cannot
[Solution Description]
Totipotent stem cells can differentiate into all cell types, including embryonic and extraembryonic tissues, and can form a complete organism. Pluripotent stem cells can differentiate into any of the three germ layers but not extraembryonic tissues.

Key Concept: Characteristics of Stem Cells

a) Fully specialized cells that perform specific functions
[Solution Description]
Stem cells are known for being progenitor cells, capable of self-renewal, and having multilineage differentiation potential. They are also used in treating diseases. However, they are undifferentiated and unspecialized cells, not fully specialized.

Key Concept: Characteristics of Stem Cells

b) Functionally specialized at the time of isolation
[Solution Description]
Stem cells possess self-renewal capacity, multilineage differentiation potential, and are progenitor cells. They are undifferentiated and unspecialized but do not exhibit immediate functionality in specialized roles. Their therapeutic use arises from their ability to differentiate rather than being inherently functional in specific roles.

Key Concept: Stem Cell Therapy

c) Alzheimer's disease
[Solution Description]
Stem cell therapy is commonly used for blood-related disorders like leukemia, immune deficiencies such as SCID, and regenerative treatments for Parkinson's disease and spinal cord injuries. However, it is not a standard treatment for Alzheimer's disease, where neuronal degeneration is more complex and widespread.

Key Concept: Types of Stem Cells

d) Totipotent stem cells
[Solution Description]
Totipotent stem cells have the highest differentiation potential as they can give rise to all embryonic and extraembryonic cell types, including forming a complete organism. Embryonic stem cells are pluripotent, while foetal and adult stem cells have limited differentiation capabilities.

Key Concept: Diabetes Treatment

c) By producing insulin through pancreatic beta cells
[Solution Description]
Stem cells can be differentiated into pancreatic beta cells, which produce insulin. This approach holds promise for restoring insulin production in diabetic patients, offering a potential cure or long-term treatment for diabetes.

Key Concept: Neurodegenerative Diseases

c) Parkinson's disease
[Solution Description]
Stem cells have the potential to replace damaged neurons in neurodegenerative diseases such as Parkinson's disease. The ability of stem cells to differentiate into specialized cells makes them a promising therapy for conditions where neurons are lost or dysfunctional.

Key Concept: Regenerative Medicine

c) Bone marrow transplants for blood disorders
[Solution Description]
Hematopoietic stem cells are primarily used in bone marrow transplants to treat blood disorders such as leukemia. These stem cells can differentiate into various blood cell types, making them essential for regenerating healthy blood cells in patients with damaged or diseased bone marrow.

Key Concept: Multipotent Stem Cells

c) A limited range of cell types within a particular lineage
[Solution Description]
Multipotent stem cells have restricted differentiation potential compared to totipotent and pluripotent cells. They can only differentiate into a limited range of cell types within a particular lineage, such as hematopoietic stem cells giving rise to blood cells.

Key Concept: Pluripotent Stem Cells

d) They are descendants of totipotent cells but cannot form a complete organism
[Solution Description]
Pluripotent stem cells are descendants of totipotent cells but cannot form a complete organism. They can differentiate into all cell types except extra-embryonic tissues (which totipotent cells can).

Key Concept: Totipotent Stem Cells

c) Each cell can develop into a complete organism
[Solution Description]
Totipotent stem cells can develop into a complete organism and differentiate into embryonic cell types. They are produced by early blastomeres. The other options either describe pluripotent or multipotent cells, which have lesser differentiation potential.

Key Concept: Types of Stem Cells

b) Human blastocyst
[Solution Description]
Embryonic stem cells are the most versatile and are isolated from the human blastocyst stage of development. They possess high potential for transplantation and therapeutic use.

Key Concept: Potency of Stem Cells

c) Totipotent stem cells
[Solution Description]
Totipotent stem cells are capable of differentiating into all embryonic cell types and can develop into a complete organism. They are produced by early blastomeres and represent the highest potency among stem cells.

Key Concept: Characteristics of Stem Cells

c) They are fully differentiated cells.
[Solution Description]
Stem cells are undifferentiated, unspecialized cells capable of self-renewal and multilineage differentiation. They are used for treating diseases but do not have fully developed specialized functions. The correct answer identifies the option that does not describe a characteristic of stem cells.

Key Concept: Potency of Stem Cells

d) Totipotent stem cells
[Solution Description]
Totipotent stem cells have the highest differentiation potential and can develop into a complete organism, as they can form all embryonic and extraembryonic tissues.

Key Concept: Types of Stem Cells

c) Embryonic stem cells
[Solution Description]
Embryonic stem cells are isolated from human blastocysts and are considered the most versatile type of stem cells, with high potential for transplant use.

Key Concept: Basic Concept

c) They have the capacity of multilineage differentiation.
[Solution Description]
Stem cells are undifferentiated and have the potential to differentiate into different specialized cell types due to their property of multilineage differentiation, which is one of their key characteristics.

Key Concept: Chimeric viruses, Vaccine safety

b) The chimeric design limits viral replication while maintaining immunogenicity
[Solution Description]
Dengvaxia uses a chimeric virus where dengue virus genes are inserted into yellow fever vaccine backbone. This creates a hybrid virus that can replicate enough to stimulate immunity but cannot cause severe disease because: 1) The structural modifications limit virulence, 2) It combines known safety of yellow fever vaccine strain with dengue immunogenicity, and 3) The chimeric design prevents reversion to wild-type virulence - a risk with conventional attenuation methods.

Key Concept: mRNA vaccines, Antigen presentation

d) mRNA vaccines lead to endogenous antigen production and dual MHC presentation unlike whole-virus presentation
[Solution Description]
In mRNA vaccines like Pfizer-BioNTech, host cells translate the mRNA to produce spike proteins which are then presented via MHC class I and II pathways, activating both cytotoxic T-cells and helper T-cells. Traditional live-attenuated vaccines present whole viral proteins through infected cells and professional antigen-presenting cells, potentially triggering broader but less specific immune responses. The key difference is that mRNA vaccines bypass viral infection while still achieving endogenous antigen production and presentation.

Key Concept: Recombinant DNA technology, Viral capsid proteins

d) Produces VLPs by expressing L1 proteins in yeast/insect cells that mimic viral structure
[Solution Description]
The HPV vaccine uses recombinant DNA technology where genes for viral capsid protein L1 are expressed in yeast or insect cells to produce Virus-Like Particles (VLPs). These VLPs mimic the natural virus structure but contain no viral DNA, making them non-infectious while still triggering strong immune responses. This is because the immune system recognizes the same surface antigens as the real virus.

Key Concept: Edible vaccines, GEAC regulations

c) Genetic Engineering Approval Committee (GEAC)
[Solution Description]
The Genetic Engineering Approval Committee (GEAC) is India's regulatory body for evaluating the environmental and public health safety of genetically modified organisms (GMOs), including edible vaccines. While ICMR and CDSCO oversee clinical trials and drug standards, GEAC specifically assesses GMO-related risks. The solution hinges on identifying GEAC's role in GM crop and organism regulation.

Key Concept: DNA vaccines, Immune response

b) Production of the antigen by host cells, leading to an immune response
[Solution Description]
DNA vaccines work by introducing engineered DNA into host cells, which then express the encoded antigenic protein. This triggers both humoral and cellular immune responses because the host's own cells produce the antigen, mimicking natural infection. The correct answer involves understanding that DNA vaccines stimulate antigen production within host cells, not direct antibody introduction or pathogen replication.

Key Concept: Protein vaccines, DNA vaccines

a) Protein vaccine
[Solution Description]
This question tests knowledge of protein-based recombinant vaccines. The key detail here is that the vaccine uses a specific viral protein (antigen) produced via recombinant DNA technology in yeast cells. Such vaccines are classified as **protein vaccines**, as they rely on the expression of pathogen-derived proteins to elicit immunity. Examples include the Hepatitis B vaccine, where HBsAg is expressed in yeast.

Key Concept: Molecular Diagnosis, PCR

d) Polymerase Chain Reaction (PCR)
[Solution Description]
Polymerase Chain Reaction (PCR) is the most suitable technique for amplifying a specific DNA sequence. It allows for the exponential amplification of target DNA sequences, making it highly sensitive for detecting even small amounts of DNA or specific mutations. ELISA detects proteins, DNA microarrays analyze gene expression, and Western blotting identifies proteins based on size and antibody binding, none of which are designed for DNA sequence amplification.

Key Concept: Stem Cell Technology, Potency of Stem Cells

b) Pluripotent stem cells
[Solution Description]
Pluripotent stem cells can differentiate into all cell types of an organism but cannot form extraembryonic tissues like the placenta. This distinguishes them from totipotent stem cells, which can form both embryonic and extraembryonic tissues. Multipotent stem cells are more limited, differentiating only into closely related cell types, while unipotent stem cells can produce only one cell type.

Key Concept: Recombinant Vaccines, DNA Vaccines

d) The vaccine injects DNA encoding pathogen proteins, leading to their expression in host cells.
[Solution Description]
The recombinant DNA vaccine contains genetically engineered DNA that encodes antigenic proteins of the pathogen. When injected into the host, the host cells take up the DNA and express the encoded proteins. These proteins are then recognized as foreign by the immune system, triggering an immune response. Unlike traditional vaccines, DNA vaccines directly introduce genetic material encoding antigens rather than the antigens themselves or live attenuated pathogens.

Key Concept: Live Attenuated Vaccines

b) It contains live attenuated viruses that may cause infection
[Solution Description]
The rotavirus vaccine contains live attenuated viruses, which are weakened forms of the virus. Immunocompromised individuals have weakened immune systems, making them more susceptible to infections caused by even weakened viruses, hence the vaccine is not recommended for them.